AKTS Aktis Oncology
Aktis Oncology earnings company data as of 7:04 PM ET 11/19
- 0 of 2 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2027 Q1 | 12 Nov | EPS | -0.45 | -0.54 | Miss |
| Rev | $2.5M | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | -0.43 | -0.44 | Miss |
| Rev | — | $3.4M | — |
Insider trades
Open-market buys and sales by AKTS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $114M bought by 6 insiders
- $3M sold by 3 insiders outside a trading plan
- $259K sold by 1 insider under 10b5-1 plans
-
Akos Czibere Chief Medical OfficerPlanned sale$259K 12,500 shares at $20.69 100% of stakeTraded Sep 23 Filed Sep 24
-
Ken Herrmann DirectorSale$119K 4,856 shares at $24.56 100% of stakeTraded Jul 20 Filed Jul 21
-
Ken Herrmann DirectorSale$77K 3,065 shares at $25.21 100% of stakeTraded Jul 17 Filed Jul 20
-
Shulamit Ron-Bigger COOSale$1.4M 50,000 shares at $27.75 100% of stakeTraded Jul 8 Filed Jul 10
-
Akos Czibere Chief Medical OfficerSale$1.4M 50,000 shares at $27.77 100% of stakeTraded Jul 8 Filed Jul 10
-
Todd Foley DirectorBuy$4.2M 232,870 shares at $18.00 +5.8% to stakeTraded Jan 12 Filed Jan 14
-
Mpm Bioventures 2018, L.P. 10% owner, +7 joint filersBuy$20M 1,112,777 shares at $18.00 +12% to stakeTraded Jan 12 Filed Jan 14
-
Vida Ventures II, LLC 10% owner, +1 joint filerBuy$15M 835,000 shares at $18.00 New stakeTraded Jan 12 Filed Jan 12
-
EcoR1 Capital, LLC Director, +1 joint filerBuy$40M 2,222,222 shares at $18.00 New stakeTraded Jan 12 Filed Jan 12
Also filed in the last 12 months, not counted as buying or selling: 17 conversions and 7 option exercises.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| 424B4 | Filing Doc | ||
| S-1/A | Filing Doc | ||
| S-1/A | Filing Doc | ||
| S-1 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon